filmov
tv
Kernel x Cybin Announce Ketamine Pilot Results

Показать описание
Kernel & Cybin are announcing pilot results from a feasibility study evaluating Kernel’s quantitative neuroimaging technology, Flow, to measure cortical hemodynamics of the brain while experiencing ketamine. Kernel Founder/CEO Bryan Johnson volunteered as the first pilot participant in the study.
Early data from the piloting suggested that ketamine-induced changes in the functional connectivity of the subject's brain lingered for several days after administration. Kernel Flow successfully measured the neuro-effect of ketamine over 11 days (baseline at Days 1-5, dosing at Day 6, follow-up at Days 7-11), and confirmed changes in functional connectivity that are consistent with current scientific research.
Psychedelics have unique powers to improve mental wellness. Flow gives its potential by introducing a data-driven approach for discovery, protocol development and personalization. We’re excited to report the pilot results of a longitudinally rich dataset of brain activity before, during and after a ketamine-induced altered-state experience. The quality of the data recorded with Flow may lead to a better understanding of the neuro effects of psychedelics on the brain and help to advance these powerful new therapies for patients.
Our brain knows things that we don’t. Wisdom we want, need and must know. Now we can.
Follow Kernel:
Kernel has effectively turned a $3m fMRI machine into a light wearable helmet. We are a world-class team of engineers, neuroscientists, physicists and operators working to make measurement of the brain and mind mainstream.
Follow Bryan Johnson:
Bryan sold his company Braintree Venmo to PayPal for $800 million which he used to fund Kernel, builder of the world’s most versatile next-generation, non-invasive brain-machine interface.
If you liked this video make sure to subscribe to our channel to stay up to date.
Early data from the piloting suggested that ketamine-induced changes in the functional connectivity of the subject's brain lingered for several days after administration. Kernel Flow successfully measured the neuro-effect of ketamine over 11 days (baseline at Days 1-5, dosing at Day 6, follow-up at Days 7-11), and confirmed changes in functional connectivity that are consistent with current scientific research.
Psychedelics have unique powers to improve mental wellness. Flow gives its potential by introducing a data-driven approach for discovery, protocol development and personalization. We’re excited to report the pilot results of a longitudinally rich dataset of brain activity before, during and after a ketamine-induced altered-state experience. The quality of the data recorded with Flow may lead to a better understanding of the neuro effects of psychedelics on the brain and help to advance these powerful new therapies for patients.
Our brain knows things that we don’t. Wisdom we want, need and must know. Now we can.
Follow Kernel:
Kernel has effectively turned a $3m fMRI machine into a light wearable helmet. We are a world-class team of engineers, neuroscientists, physicists and operators working to make measurement of the brain and mind mainstream.
Follow Bryan Johnson:
Bryan sold his company Braintree Venmo to PayPal for $800 million which he used to fund Kernel, builder of the world’s most versatile next-generation, non-invasive brain-machine interface.
If you liked this video make sure to subscribe to our channel to stay up to date.
Комментарии